No Image
Monoclonal Antibodies
Rabbit anti-Human CD307a/FCRL1 Monoclonal Antibody for FC - Q96LA6
Item Number : CM0010267
Price varies based on specs and customizations
- Application
- FC
- Cross Reactivity
- Human
- Protein Weight
- 47kDa/40kDa/22kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | Rabbit anti-Human CD307a/FCRL1 mAb |
| Remarks/Alias | FCRH1; IFGP1; IRTA5; CD307a |
| Species | Human |
| Gene ID (Human) | 115350 |
| Gene ID | 115350 |
| Immunogen | Recombinant protein; Recombinant fusion protein containing a sequence corresponding to amino acids 17-303 of human CD307a/FCRL1 (NP_443170.1) |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | FC |
| Cross Reactivity | Human |
| SWISS | Q96LA6 |
| Protein Weight | 47kDa/40kDa/22kDa |
| Shipping | Ice bag |
Biological Background: Fc receptor-like protein 1 (FCRL1/CD307a) Function and Localization
- FCRL1 (Fc receptor-like protein 1), also known as FcRH1, IFGP1, and IRTA5, is a type I transmembrane glycoprotein belonging to the immunoglobulin superfamily.
- It is preferentially expressed on mature B-cells and functions as a regulator of B-cell antigen receptor (BCR) signaling, fine-tuning B-cell activation and homeostasis. Related references: PMID:15479727
- FCRL1 recruits ABL1 as an intracellular effector to enhance B-cell activation, while simultaneously suppressing ERK activation in a GRB2-dependent manner under both homeostatic and BCR-stimulated conditions (By similarity).
- The protein is localized to the cell membrane, with its extracellular region containing immunoglobulin-like domains likely involved in ligand binding.
- FCRL1 undergoes alternative splicing, producing isoforms with different molecular weights (predicted ~47, 40, and 22 kDa), and is subject to post-translational modifications including glycosylation and phosphorylation.
- Tissue specificity is primarily in secondary lymphoid organs (spleen, lymph node), with higher expression in naive compared to memory B-cells; also detected at low levels in heart, skeletal muscle, kidney, liver, and placenta.
Experimental Guidance and Technical Tips
- The immunogen (aa 17-303) corresponds to the extracellular domain of human FCRL1, ensuring that the antibody binds to the native surface-expressed protein. For flow cytometry applications, this design supports detection of membrane-bound FCRL1 on live cells.
- Consider titrating the antibody to determine the optimal staining concentration for your specific experimental conditions, as staining intensity may vary with cell type and activation state.
- Use appropriate Fc receptor blocking reagents and isotype controls to minimize non-specific binding, especially when analyzing B-cell populations.
- Validate antibody performance in your sample system by including positive (e.g., human B-cell lines or peripheral blood B-cells) and negative (T-cells) controls.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio serves as a comprehensive IVD raw-material provider, connecting diagnostic manufacturers and research laboratories with high-quality antibodies like this FCRL1 clone. We support B-cell immunophenotyping projects by offering validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and tailored rare target sourcing. Let CamelBio streamline your procurement from concept to clinic.
Product Datasheet
Rabbit anti-Human CD307a/FCRL1 Monoclonal Antibody for FC - Q96LA6
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!